Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tirofiban in Patients With Acute Branch Atheromatous Disease (BAD)- Related Stroke (BRANT)

NCT06037889 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT06037889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06037889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tirofiban in Patients With Acute Branch Atheromatous Disease (BAD)- Related Stroke (BRANT)
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 3
Overall status
Completed
Start date
November 9, 2023
Completion date
February 26, 2026
Enrollment
516 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

branch atheromatous disease